Login
$BHC
$6.31 -$0.04 (0.63%) Close

$BHC SEC Filings

Filed On Filing
02 Oct 2026 Form 4: Paulson John, Director

Received 10,720 shares as a grant or award ($62.5K)

02 Oct 2026 Form 4: Leung Sandra, Director

Received 5,789 shares as a grant or award ($33.7K)

02 Oct 2026 Form 4: Wechsler Amy B, Director

Received 1,179 shares as a grant or award ($6.87K)

20 Aug 2026 Form 4: Lenar Aimee J., President, US Pharma

Sold 36,827 shares ($259K)

19 Aug 2026 144
30 Jul 2026 10-Q
29 Jul 2026 8-K: Results of Operations and Financial Condition
20 Jul 2026 Form 4: Lenar Aimee J., President, US Pharma

Gave up 5,260 shares to cover exercise price or tax ($25.4K)

17 Jul 2026 Form 4: Lenar Aimee J., President, US Pharma

Gave up 23,395 shares to cover exercise price or tax ($114K)

15 Jul 2026 Form 4: Lee Steven Hyosig, SVP, Controller & CAO

Gave up 3,125 shares to cover exercise price or tax ($14.8K)

02 Jul 2026 Form 4: Wechsler Amy B, Director

Received 1,394 shares as a grant or award ($6.87K)

02 Jul 2026 Form 4: Paulson John, Director

Received 12,677 shares as a grant or award ($62.5K)

02 Jul 2026 Form 4: Leung Sandra, Director

Received 6,845 shares as a grant or award ($33.7K)

01 Jul 2026 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
01 Jun 2026 SD
26 May 2026 Form 4: Wechsler Amy B, Director

Received 45,871 shares as a grant or award

26 May 2026 Form 4: Roberts Eiry, Director

Received 45,871 shares as a grant or award

26 May 2026 Form 4: Power Robert N, Director

Received 45,871 shares as a grant or award

26 May 2026 Form 4: Paulson John, Director

Received 45,871 shares as a grant or award

26 May 2026 Form 4: Leung Sandra, Director

Received 45,871 shares as a grant or award

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support